Georgia
ATLANTA, March 19 /PRNewswire-FirstCall/ --- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, today responded to Medafor's allegation that it has repudiated the Exclusive Distribution Agreement ("Agreement") between the two companies.
On March 18, 2010, Medafor informed CryoLife that it is treating the Agreement as
News articles for The Fifth Decennial International Conference on Healthcare-Associated Infections:
ATLANTA, March 19 /PRNewswire-USNewswire/ -- Scientists at The Virginia Commonwealth University Medical Center found a compliance with non-pathogen specific infection control practices such as hand hygiene, efforts to reduce device-related infections and chlorhexidine bathing, is successful for reducing rates of healthcare-associated methicillin-resistant Staphylococcus aureus. The findings were presented at
Success Accelerators announces “Your Business … Accelerated,” part of
their 4 City Tour, is scheduled for the Westin Peachtree Plaza in
downtown Atlanta, GA on May 13, 2010.
Copyright © Business Wire 2010
ATLANTA, March 18 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it has sent the following letter to Medafor's Board of Directors:
March 18, 2010
VIA FEDEX
Michael F. Pasquale, Chairman of the Board
Medafor, Inc.
Dear Michael,
NORCROSS, Ga., March 18 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will release its fiscal 2010 third quarter earnings on Wednesday, March 31, 2010 after the market close. The Company will host a conference
Allconnect – the leading comparison shopping and connections marketplace
for essential home services – has signed a series of partnerships with
real estate companies that will expand Allconnect’s
Copyright © Business Wire 2010
Independent
risk management software company Riskonnect, Inc. continues
on a rapid pace of hiring world-class talent with the announcement today
of David Wood as
Copyright © Business Wire 2010
Companies mentioned in this article:
nuBridges
nuBridges
announced today that Network Products Guide, the industry’s leading
information technology research and advisory guide, has named nuBridges
Exchange™ Enterprise a
Copyright © Business Wire 2010
NORCROSS, Ga., March 18 /PRNewswire-FirstCall/ -- BravePoint,® Inc. has announced the launch of its new product, Evolution, to provide a well-defined approach to companies that need to renovate existing OpenEdge applications or build new ones while taking advantage of rich Web 2.0 Ajax technology.
An Evolution engagement delivers the Evolution
Orange Business Services has been placed in the Leaders quadrant in
Gartner Inc.’s three latest reports. Based on its completeness of vision
and ability to execute, Gartner named
Copyright © Business Wire 2010
NCR Corporation (NYSE: NCR) today named Robert Fishman as its Chief
Financial Officer, reporting to NCR Chairman and Chief Executive
Officer, Bill Nuti. Fishman, 46, has been serving
Copyright © Business Wire 2010
Eclipsys Corporation® (NASDAQ: ECLP), The Outcomes Company®,
today announced that Singapore General Hospital (SGH), Singapore’s
oldest and largest acute tertiary hospital and national referral center,
Copyright © Business Wire 2010
NORCROSS, Ga., March 18 /PRNewswire-FirstCall/ -- Simtrol, Inc. (OTC Bulletin Board: SMRL), an innovative developer of enterprise-class software solutions that manage the extended network of connected devices, today announced the latest release of its Device Manager(TM) (DM) software. In addition to enhanced device management functionality and greater scalability, DM5.0
ATLANTA, March 18 /PRNewswire/ -- Nearly 14 percent of Medicare beneficiaries admitted with a primary diagnosis of ST-Segment Elevation Myocardial Infarction (STEMI) undergo multi-vessel primary percutaneous coronary intervention (PCI), despite recommendations from the American College of Cardiology and the American Heart Association to intervene on only the culprit vessel. Those